Apyx Medical (APYX) EPS (Basic) Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Apyx Medical | 174.53 Mn | 143.65 Mn | 7.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.61% |
| Dec 31, 2025 | 9.71% |
| Sep 30, 2025 | 14.59% |
| Jun 30, 2025 | 8.46% |
| Mar 31, 2025 | -10.76% |
| Dec 31, 2024 | 5.59% |
| Sep 30, 2024 | -1.49% |
| Jun 30, 2024 | -7.89% |
| Mar 31, 2024 | -5.29% |
| Dec 31, 2023 | 69.14% |
| Sep 30, 2023 | -15.58% |
| Jun 30, 2023 | 68.71% |
| Mar 31, 2023 | -4.56% |
| Dec 31, 2022 | 71.47% |
| Sep 30, 2022 | -13.56% |
| Jun 30, 2022 | 73.82% |
| Mar 31, 2022 | 73.50% |
| Dec 31, 2021 | -24.57% |
| Sep 30, 2021 | -24.57% |
| Jun 30, 2021 | -43.10% |
| Mar 31, 2021 | -14.87% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | -12.89% |
| Jun 30, 2020 | -18.47% |
| Mar 31, 2020 | -15.85% |
| Dec 31, 2019 | 12.39% |
| Sep 30, 2019 | 5.22% |
| Jun 30, 2019 | -141.07% |
| Mar 31, 2019 | 20.93% |
| Dec 31, 2018 | -221.75% |
| Sep 30, 2018 | 154.13% |
| Jun 30, 2018 | -178.21% |
| Mar 31, 2018 | -31.95% |
| Dec 31, 2017 | -437.87% |
| Sep 30, 2017 | 25.69% |
| Jun 30, 2017 | -564.97% |
| Mar 31, 2017 | -564.97% |
| Dec 31, 2016 | 16.74% |
| Sep 30, 2016 | -67.46% |
| Jun 30, 2016 | -24.57% |
| Mar 31, 2016 | -34.08% |
| Dec 31, 2015 | 8.97% |